Related Experiment Videos

2,3-Butanedione monoxime protects mice against the convulsant effect of picrotoxin by facilitating GABA-activated

T Brightman1, J H Ye, E Ortiz-Jimenez

  • 1Department of Pharmacology and Toxicology, New Jersey Medical School (UMDNJ), Newark 07103-2714, USA.

Brain Research
|April 24, 1995
PubMed

Insights

2,3-butanedione monoxime (BDM) suppressed seizures in mice by enhancing GABA

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Picrotoxin (PTX) induces seizures in adult mice.
  • 2,3-butanedione monoxime (BDM) exhibits anticonvulsant properties.
  • A BDM analogue, 2,3-butanedione (BTD), lacks anticonvulsant effects.

Purpose of the Study:

  • To investigate the mechanism underlying BDM's anticonvulsant activity.
  • To determine BDM's effect on GABA-activated currents (IGABA).

Main Methods:

  • In vivo seizure suppression tests in mice.
  • Electrophysiological recordings of IGABA in cortical and hypothalamic neurons.
  • Application of BDM and BTD at various concentrations.

Main Results:

  • BDM significantly reduced PTX-induced seizures.
  • BDM demonstrated a biphasic effect on IGABA: potentiation at low concentrations and inhibition at high concentrations.
  • BTD had no effect on IGABA.
  • BDM mitigated PTX's inhibitory effect on IGABA.

Conclusions:

  • BDM's anticonvulsant action is mediated by its interaction with GABAergic neurotransmission.
  • Oximes, like BDM, may exert anticonvulsant effects by facilitating GABA's inhibitory actions.

Related Concept Videos